Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Rewinding RX vs Vea Health

Rewinding RX
Graded #340

Higher grade

vs+4.5
Vea Health
Graded #451

Lower grade

The verdict

Rewinding RX takes it — 59.5/100 to 55/100.

Rewinding RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Rewinding RX is a longevity-focused telehealth platform that frames compounded GLP-1 therapy within a broader biological-age-reversal program alongside NAD+ and functional-medicine protocols.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
45
45
Dose & formulationVea Health +11
40
51
Clinical oversightRewinding RX +19
85
66
Labs & monitoringRewinding RX +1
53
52
FulfillmentRewinding RX +19
87
68
Contract termsRewinding RX +6
61
55
Rewinding RX · left barVea Health · right bar

The numbers

MetricRewinding RXVea Health
WeighScore59.5/10055/100
GradeCC
Scorecard rank#340#451
SemaglutideNot disclosedNot disclosed
TirzepatideNot disclosedNot disclosed
CoverageAll 50 statesAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
Rewinding RX

Graded #340 · C

Strengths

  • LegitScript Certified
  • Publishes the FDA compounded-medication disclaimer — uncommon transparency
  • MD-only physician network ('never a physician assistant or nurse')
  • All-50-state coverage with physician state-licensing matching
  • Corporate entity disclosed (Rewinding RX Ltd.)

Where it loses points

  • Pricing not shown — fully gated behind sign-up
  • Pharmacy partner not named (only generic 503A/503B references)
  • Medical director / clinical leadership not disclosed
  • Governing law, arbitration venue, and corporate address not disclosed
  • Tirzepatide not listed on the homepage (semaglutide only confirmed)
Vea Health

Graded #451 · C

Strengths

  • Publishes the FDA compounded-medication disclaimer
  • Oral and injection protocols for both semaglutide and tirzepatide
  • Claims 50-state coverage via a clinician network
  • Clearly differentiated positioning (longevity, men's health, performance)

Where it loses points

  • Pricing not shown until after sign-up
  • Pharmacy partner not named (only 'U.S.-based pharmacy')
  • LegitScript certification status not visible
  • No named medical director
  • 503A vs 503B designation not specified

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard